Phil Grayeski

Phil Grayeski is a highly educated professional with a diverse academic background. He holds a MD in Medicine from the University of North Carolina at Chapel Hill School of Medicine, a PhD in Genetics from the same institution, a Master of Philosophy in Bioscience Enterprise from the University of Cambridge, and a Bachelor of Science in Genetics and Chemistry from The University of Georgia.

Phil Grayeski has been involved in various organizations, showcasing his expertise and leadership. He has served as a Board Member at Cyberdontics, formerly held the same position at Dimension Inx, and was a Partner at KdT Ventures. Additionally, he has been a Board Member at Transcera Inc. and Andes, as well as the Co-Founder of Torque Bio. Phil also held roles as a Principal and Venture Associate at KdT Ventures, and as a Strategy Advisor and Business Analyst at Ribometrix, Inc. and StrideBio, Inc. He started his career as a US Medical Business Support Planning Intern at Novartis and has worked as a Research Assistant at various prestigious institutions such as Dana-Farber Cancer Institute, Ludwig Maximilian University of Munich in Germany, and the University of Georgia - Franklin College of Arts and Sciences.